Dark

UTHR
United Therapeutics Corp
stock NASDAQ

At Close

Jul 8, 2025 3:59:31 PM EDT

294.36USD+1.367%(+3.97)449,931

294.84Bid 295.32Ask 0.48Spread

Pre-market

0.00USD-100.000%(-290.39)0

After-hours

Jul 8, 2025 4:03:30 PM EDT

294.42USD+0.020%(+0.06)19,707

OverviewOptionsHistoricalExchangesShortsNews

Jan 21, 2022

06:02AM EST United Therapeutics Outlines Achievements Of Its Xenotransplantation Programs Benzinga

06:00AM EST United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs Business Wire

Jan 4, 2022

08:11AM EST The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives Benzinga

Dec 30, 2021

06:00AM EST United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst Business Wire

Dec 27, 2021

06:14AM EST United Therapeutics Announces Co. Has Resubmitted Its New Drug Application To The FDA For Tyvaso DPI Benzinga

Dec 3, 2021

06:00AM EST United Therapeutics Named by Newsweek as One of America's Most Responsible Companies 2022 Business Wire

Nov 8, 2021

10:12AM EST Liquidia's Inhaled Treprostinil Powder Scores Tentative FDA Approval For PAH Benzinga

Nov 3, 2021

12:05PM EDT United Therapeutics Earnings Perspective: Return On Capital Employed Benzinga

09:19AM EDT The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering Benzinga

09:17AM EDT Recap: United Therapeutics Q3 Earnings Benzinga

09:12AM EDT United Therapeutics Q3 Adj. EPS $4.16 Beats $3.59 Estimate, Sales $444.70M Beat $421.45M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

06:02AM EDT United Therapeutics Q3 EPS $3.42 Vs. $3.84 Last Year RTTNews

06:01AM EDT United Therapeutics Corporation Reports Third Quarter 2021 Financial Results PR Newswire

Nov 1, 2021

06:01AM EDT United Therapeutics Corporation To Present At The Credit Suisse 30th Annual PR Newswire

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 27, 2021

04:29PM EDT 3D Systems, United Therapeutics Reports Expansion Of Bioprinting Program Benzinga

06:01AM EDT United Therapeutics Corporation To Report Third Quarter 2021 Financial Results PR Newswire

Oct 21, 2021

12:11PM EDT United Therapeutics Details New Data Presented At CHEST Annual Meeting 2021 Benzinga

Oct 18, 2021

06:06AM EDT United Therapeutics Provides An Update On The Progress Of The Tyvaso DPI New Drug Application Benzinga

06:01AM EDT United Therapeutics Provides an Update on the Progress of the Tyvaso DPI(tm) PR Newswire

Oct 13, 2021

01:38PM EDT Shares Of United Therapeutics Quiet; Gizmodo Report 'Drone Delivers Lungs to Transplant Recipient, a Medical First' Mentions Co Benzinga

Oct 11, 2021

06:01AM EDT United Therapeutics to Present New Data at CHEST Annual Meeting 2021 PR Newswire

Oct 1, 2021

02:29PM EDT Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates Benzinga

Sep 30, 2021

04:31PM EDT United Therapeutics Converts To A Public Benefit Corporation Following Shareholder Approval Benzinga

04:31PM EDT United Therapeutics Converts to a Public Benefit Corporation Following PR Newswire

Sep 10, 2021

06:00AM EDT United Therapeutics Releases its Annual Corporate Responsibility Report PR Newswire

Sep 7, 2021

09:54AM EDT United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients Benzinga

06:03AM EDT United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021 RTTNews

06:01AM EDT United Therapeutics Presents Tyvaso DPI(tm) BREEZE Clinical Data At The PR Newswire

Aug 25, 2021

06:08AM EDT United Therapeutics, Former NFL Player Devon Still, Daughter Leah To Launch "Braving NeuroBLASToma" RTTNews

06:01AM EDT Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month PR Newswire

Aug 24, 2021

06:06AM EDT United Therapeutics To Present Tyvaso DPI BREEZE Clinical Data At The European Respiratory Society International Congress 2021 Sept. 5-8 Benzinga

06:05AM EDT United Therapeutics To Present Tyvaso DPI BREEZE Clinical Data At ERS International Congress 2021 RTTNews

06:01AM EDT United Therapeutics to Present Tyvaso DPI(tm) BREEZE Clinical Data at the PR Newswire

Aug 4, 2021

07:11AM EDT United Therapeutics: Q2 Earnings Insights Benzinga

06:51AM EDT A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of General Motors Earnings Benzinga

06:05AM EDT United Therapeutics Q2 EPS $3.65 Vs. $2.41 Last Year RTTNews

06:03AM EDT A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings Benzinga

06:02AM EDT United Therapeutics Q2 Adj. EPS $4.09 Beats $3.02 Estimate, Sales $446.50M Beat $378.75M Estimate Benzinga

06:01AM EDT United Therapeutics Corporation Reports Second Quarter 2021 Financial Results PR Newswire

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 3, 2021

06:01AM EDT United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow PR Newswire

Jul 28, 2021

06:01AM EDT United Therapeutics Corporation To Report Second Quarter 2021 Financial Results PR Newswire

Jul 14, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 Benzinga

08:14AM EDT Argus Research Upgrades United Therapeutics to Buy, Announces $205 Price Target Benzinga

Jun 30, 2021

06:01AM EDT United Therapeutics Highlights The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso INCREASE Study Benzinga

06:01AM EDT United Therapeutics Announces The Lancet Respiratory Medicine Publication Of PR Newswire

Jun 23, 2021

06:20AM EDT United Therapeutics And Medtronic Discontinue Further Efforts To Develop & Commercialize Implantable System For Remodulin Based On Evolution Of Treatment Options, Paradigms In Pulmonary Arterial Hypertension Over Past Few Years Benzinga

Jun 16, 2021

11:03AM EDT MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD RTTNews

11:00AM EDT MannKind And United Therapeutics Achieve A Major Milestone In The Development PR Newswire

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

07:26AM EDT MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension Benzinga

06:56AM EDT United Therapeutics Corporation (UTHR) Wednesday said that the U.S. Food and Drug Administration has accepted for priority review the New Drug Application (NDA) for Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. RTTNews

06:15AM EDT -- Tyvaso DPI includes the second compound formulated with MannKinds Technosphere technology to be reviewed by the FDA -- FDA review expected to be complete in October 2021 -- Hiring expansion underway at MannKinds manufacturing facility in Connecticut GlobeNewswire Inc

06:08AM EDT United Therapeutics Announces FDA Acceptance Of Tyvaso DPI New Drug Application For Priority Review Benzinga

06:04AM EDT United Therapeutics: FDA Accepts Tyvaso DPI NDA For Priority Review RTTNews

06:02AM EDT United Therapeutics Announces FDA Acceptance Of Tyvaso DPI New Drug Application For Priority Review Benzinga

06:01AM EDT United Therapeutics Announces FDA Acceptance of Tyvaso DPI(tm) New Drug PR Newswire

Jun 7, 2021

06:02AM EDT United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia RTTNews

06:02AM EDT United Therapeutics Pursues Additional Claims For Trade Secret Misappropriation Against Liquidia And A Former United Employee; Claims Allege Liquidia 'conspired with the former employee to misappropriate United Therapeutics' trade secrets' Benzinga

06:01AM EDT United Therapeutics Pursues New Claims For Trade Secret Misappropriation PR Newswire

Jun 3, 2021

06:05AM EDT United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis Benzinga

06:05AM EDT United Therapeutics Enrolls First Patient In Phase 3 TETON Study Of Tyvaso In Idiopathic Pulmonary Fibrosis RTTNews

06:01AM EDT United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of PR Newswire

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

06:01AM EDT United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare PR Newswire

May 6, 2021

09:58AM EDT Price Over Earnings Overview: United Therapeutics Benzinga

08:01AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

06:54AM EDT HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $248 Benzinga

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

07:12AM EDT United Therapeutics: Q1 Earnings Insights Benzinga

06:24AM EDT United Therapeutics Q1 EPS $0.63; Non-GAP EPS $3.49 RTTNews

06:12AM EDT A Peek Into The Markets: US Stock Futures Gain; General Motors Earnings In Focus Benzinga

06:06AM EDT United Therapeutics Q1 Adj. EPS $3.49 Beats $2.94 Estimate, Sales $379.10M Beat $368.95M Estimate Benzinga

06:01AM EDT United Therapeutics Corporation Reports First Quarter 2021 Financial Results PR Newswire

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 26, 2021

06:01AM EDT United Therapeutics Corporation To Report First Quarter 2021 Financial Results PR Newswire

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 19, 2021

07:11AM EDT MannKind Corporation (MNKD) and United Therapeutics (UTHR) today said United Therapeutics has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for its Tyvaso DPI. RTTNews

06:09AM EDT MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI RTTNews

06:07AM EDT United Therapeutics Announces Submission Of NDA For Tyvaso DPI To FDA RTTNews

06:01AM EDT Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI With New Drug Application Submitted to the FDA Benzinga

06:01AM EDT United Therapeutics Announces Submission of Tyvaso DPI(tm) New Drug Application PR Newswire

06:00AM EDT MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the development of Tyvaso DPI as United Therapeutics submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA). GlobeNewswire Inc

Apr 8, 2021

08:12AM EDT JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $212 Benzinga

Apr 1, 2021

06:17AM EDT United Therapeutics Corporation (UTHR) announced that FDA has approved Tyvaso Inhalation Solution for the treatment of patients with pulmonary hypertension associated with interstitial lung disease to improve exercise ability. This is the second FDA-approved indication for Tyvaso. It was initially approved for the treatment of pulmonary arterial hypertension. RTTNews

06:07AM EDT United Therapeutics Reports FDA Approval And Launch Of Tyvaso For Treatment Of PH-ILD RTTNews

06:01AM EDT United Therapeutics Announces FDA Approval and Launch of Tyvaso For The Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease Benzinga

06:01AM EDT Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease PR Newswire

Mar 24, 2021

06:01AM EDT United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa PR Newswire

Mar 9, 2021

06:01AM EST United Therapeutics Corporation To Present At The Oppenheimer 31st Annual PR Newswire

Mar 3, 2021

11:05AM EST Looking Into United Therapeutics's Return On Capital Employed Benzinga

07:38AM EST United Therapeutics Pulls Plug On Trevyent Development Benzinga

06:21AM EST UPDATE: United Therapeutics Corporation Expects To Incur Charge Potentially Equal To Some Or All Of The $107.3M IPR&D Asset Benzinga

06:20AM EST UPDATE: United Therapeutics Says Discontinuing Trevyent Due To Written Comments From FDA Indicating Co. Would Need To 'both redesign the product to improve pump accuracy in certain respects and conduct a clinical study of the redesigned product' Benzinga

06:19AM EST United Therapeutics To Discontinue Development Of Trevyent Benzinga

Feb 24, 2021

04:31PM EST United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care PR Newswire

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

07:07AM EST Recap: United Therapeutics Q4 Earnings Benzinga

06:18AM EST United Therapeutics Q4 Adj. EPS Rises To $3.31 From $1.96 Prior Year RTTNews

06:05AM EST United Therapeutics Q4 Adj. EPS $3.31 Beats $3.14 Estimate, Sales $384.90M Beat $361.07M Estimate Benzinga

06:01AM EST United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 PR Newswire

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

Feb 22, 2021

09:09AM EST Credit Suisse Maintains Outperform on United Therapeutics, Raises Price Target to $196 Benzinga

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

05:20AM EST Y-mAbs Therapeutics Raises $100M Via Equity To Fund Commercial Rollout Of Neuroblastoma Med Benzinga

Feb 17, 2021

06:01AM EST United Therapeutics Corporation To Report Fourth Quarter And Full Year 2020 PR Newswire

Feb 16, 2021

09:57AM EST Oppenheimer Maintains Outperform on United Therapeutics, Raises Price Target to $275 Benzinga

Feb 10, 2021

06:19AM EST United Therapeutics Launches Commercial Sales Of Remunity Pump For Remodulin For Patients With PAH RTTNews

06:09AM EST United Therapeutics Announces Commercial Launch Of The Remunity Pump For Remodulin Benzinga

06:01AM EST United Therapeutics Announces Commercial Launch Of The Remunity(r) Pump For PR Newswire

Feb 9, 2021

12:15PM EST United Therapeutics Shares Quiet; Traders Circulate FDA Orphan Drug Designation For Co For ' Mesenchymal Stem Cell-derived Extracellular Vesicles' Benzinga

Feb 1, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2021 Benzinga

08:07AM EST 10 Biggest Price Target Changes For Monday Benzinga

06:18AM EST HC Wainwright & Co. Upgrades United Therapeutics to Buy, Raises Price Target to $195 Benzinga

Jan 28, 2021

06:18AM EST United Therapeutics Says BREEZE Study Of Investigational Tyvaso DPI Meets Primary Objective RTTNews

06:04AM EST United Therapeutics Announces Breeze Study of Investigational Tyvaso Dpi Meets Primary Objective; Study Demonstrated Safety and Tolerability of Tyvaso Dpi in Patients With Pah Transitioning From Tyvaso Inhalation Solution Benzinga

06:01AM EST United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI(tm) PR Newswire

Jan 27, 2021

08:38AM EST 3D Systems Reports Will 'Significantly' Expand Its Development Efforts Focused On Regenerative Medicine, Bioprinting Solutions; Says Decision Made Based On 'Tremendous' Progress Made In Collab With United Therapeutics Benzinga

08:37AM EST 3D Systems Announces It Will 'significantly expand its development efforts focused on regenerative medicine and bioprinting solutions' Benzinga

08:30AM EST 3D Systems Announces Breakthrough in Bioprinting Technology and GlobeNewswire Inc

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 13, 2021

05:04PM EST United Therapeutics Announces New England Journal Of Medicine Publication Of The Increase Study Evaluating Tyvason In Pulmonary Hypertension Associated With Interstitial Lung Diseases Benzinga

05:01PM EST the INCREASE Study Evaluating Tyvaso(r) in Pulmonary Hypertension Associated with Interstitial Lung Disease PR Newswire

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

Jan 5, 2021

08:39AM EST The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data Benzinga

Jan 4, 2021

06:01AM EST United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan PR Newswire

Dec 30, 2020

08:16AM EST The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data Benzinga

Dec 28, 2020

09:07AM EST Y-mAbs Therapeutics To Sell Priority Review Voucher To United Therapeutic RTTNews

09:02AM EST Y-mAbs Reports Sale Of Priority Review Voucher To United Therapeutics For $105M; BZ NOTE: United Therapeutics Announced This News At 6 a.m. Monday Benzinga

09:01AM EST United Therapeutics Reports Purchase Of Priority Review Voucher For $105M Benzinga

09:00AM EST Y-mAbs Announces Sale of Priority Review Voucher GlobeNewswire Inc

06:13AM EST United Therapeutics Plans To Apply Priority Review Voucher RTTNews

06:07AM EST United Therapeutics To Acquire A Rare Pediatric Disease Priority Review Voucher RTTNews

06:00AM EST United Therapeutics Announces Agreement To Acquire Priority Review Voucher PR Newswire

06:00AM EST United Therapeutics Reports Purchase Of Priority Review Voucher For $105M Benzinga

Dec 17, 2020

08:10AM EST The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Dec 9, 2020

11:09AM EST United Therapeutics shares were trading higher after the company announced that it received an FDA orphan drug designation for Trorstinil for the treatment of idiopathic pulmonary Fibrosis. Benzinga

06:23AM EST United Therapeutics Corp. (UTHR) said the FDA has granted orphan drug designation to treprostinil for the treatment of patients with idiopathic pulmonary fibrosis. The company plans to initiate a phase 3 study, called TETON, to evaluate the use of Tyvaso (treprostinil) Inhalation Solution in patients with idiopathic pulmonary fibrosis. RTTNews

06:06AM EST United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis Benzinga

06:03AM EST United Therapeutics Gets FDA Orphan Drug Designation For Treprostinil For Idiopathic Pulmonary Fibrosis RTTNews

06:01AM EST United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For PR Newswire

05:43AM EST United Therapeutics Received FDA Orphan Drug Designation for Treprostinil for Treatment of Idiopathic Pulmonary Fibrosis on December 8, 2020 Benzinga

05:42AM EST United Therapeutics Received FDA Orphan Drug Designation for Treprostinil for Treatment of Idiopathic Pulmonary Fibrosis Benzinga

Nov 24, 2020

06:00AM EST United Therapeutics Releases Its First Corporate Responsibility Report PR Newswire

Nov 20, 2020

08:06AM EST The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger Benzinga

Nov 17, 2020

08:32AM EST The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration Benzinga

Nov 10, 2020

06:01AM EST United Therapeutics Corporation To Present At The Jefferies Virtual London PR Newswire

Nov 5, 2020

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

Nov 4, 2020

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Nov 2, 2020

05:55AM EST United Therapeutics Corporation To Present At The Credit Suisse 29th Annual PR Newswire

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Oct 29, 2020

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 28, 2020

07:22AM EDT Recap: United Therapeutics Q3 Earnings Benzinga

06:24AM EDT United Therapeutics Q3 EPS $3.84; Non-GAAP EPS $3.88 RTTNews

06:16AM EDT United Therapeutics Q3 EPS $3.88 Beats $2.78 Estimate, Sales $380.10M Beat $356.95M Estimate Benzinga

06:01AM EDT United Therapeutics Corporation Reports Third Quarter 2020 Financial Results PR Newswire

Oct 22, 2020

06:01AM EDT United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 PR Newswire

Oct 21, 2020

06:01AM EDT United Therapeutics Corporation To Report Third Quarter 2020 Financial Results PR Newswire

Oct 15, 2020

06:05AM EDT United Therapeutics to Present New Tyvaso Clinical and Treprostinil Real-World Data at CHEST Annual Meeting 2020 Benzinga

06:01AM EDT United Therapeutics to Present New Tyvaso(r) Clinical and Treprostinil PR Newswire

Oct 14, 2020

09:27AM EDT Liquidia Technologies Announces That U.S. Patent Trial And Appeal Board Has Ruled Against United Therapeutics On Tyvaso Patents Benzinga

Sep 24, 2020

12:05AM EDT Gilead Settles US Kickback Allegations For $97M Benzinga

Sep 21, 2020

07:06AM EDT United Therapeutics Exercises its Option for an Exclusive License to CollPlant's Technology for the 3D Bioprinting of Human Kidneys Benzinga

07:01AM EDT CollPlant and United Therapeutics Announce Exercise of Option that will Expand PR Newswire

Sep 16, 2020

06:01AM EDT United Therapeutics Corporation to Present at the Oppenheimer Fall Healthcare PR Newswire

Sep 11, 2020

06:02AM EDT United Therapeutics Appoints Linda Maxwell To Board RTTNews

06:01AM EDT United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors PR Newswire

Aug 17, 2020

06:03AM EDT United Therapeutics: FDA Accepts For Review SNDA For Tyvaso Inhalation Solution RTTNews

06:01AM EDT Drug Application For Tyvaso(r) For Pulmonary Hypertension Associated With Interstitial Lung Disease PR Newswire

Aug 5, 2020

06:01AM EDT United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare PR Newswire

Jul 30, 2020

12:38PM EDT Oppenheimer Maintains Outperform on United Therapeutics, Raises Price Target to $165 Benzinga

08:25AM EDT Wedbush Maintains Outperform on United Therapeutics, Raises Price Target to $244 Benzinga

Jul 29, 2020

07:23AM EDT Recap: United Therapeutics Q2 Earnings Benzinga

06:13AM EDT United Therapeutics Q2 Adj. EPS $3.68 Beats $2.80 Estimate, Sales $362.00M Beat $338.47M Estimate Benzinga

06:11AM EDT United Therapeutics Q2 EPS $2.41 Vs. $4.66 Last Year RTTNews

06:01AM EDT United Therapeutics Corporation Reports Second Quarter 2020 Financial Results PR Newswire

04:04AM EDT Earnings Scheduled For July 29, 2020 Benzinga

Jul 24, 2020

09:12AM EDT Liquidia Technologies Issues Response To United Therapeutics Suit Alleging Infringement Of Tyvaso Patent: Notes Statutory 30-Month Stay On Regulatory Approval Is Not Associated With Allegations Of '793 Patent, Should Have No Effect On FDA Review Benzinga

Jul 23, 2020

06:04AM EDT United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia; Filed an Amended Complaint Against Liquidia Benzinga

06:01AM EDT United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia PR Newswire

Jul 22, 2020

06:01AM EDT United Therapeutics Corporation To Report Second Quarter 2020 Financial Results PR Newswire